2C-V

2C-V
Clinical data
Other names	2C-VI; 4-Ethenyl-2,5-dimethoxyphenethylamine; 4-Vinyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-ethenylphenethylamine; 2,5-Dimethoxy-4-vinylphenethylamine
Routes of; administration	Oral
Drug class	Serotonergic psychedelic; Hallucinogen
Pharmacokinetic data
Duration of action	5 hours
Identifiers
	IUPAC name 2-(4-ethenyl-2,5-dimethoxyphenyl)ethanamine;
CAS Number	2888537-57-1;
PubChem CID	57474284;
ChemSpider	129433732;
UNII	F5U9H625TA;
CompTox Dashboard (EPA)	DTXSID501337027 ;
Chemical and physical data
Formula	C12H17NO2
Molar mass	207.273 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc1cc(C=C)c(cc1CCN)OC;
	InChI InChI=1S/C12H17NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h4,7-8H,1,5-6,13H2,2-3H3; Key:LGLJOVNOGICITR-UHFFFAOYSA-N;

2C-V, or 2C-VI, also known as 4-ethenyl-2,5-dimethoxyphenethylamine, is a recreational designer drug from the substituted phenethylamine family, with psychedelic effects. It was first synthesised by Daniel Trachsel and colleagues in 2006. It is active at a dosage of 25 mg orally with a duration of around 5 hours.^[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.^[2]

References

^ ^a ^b ^c Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine Von der Struktur zur Funktion [Phenethylamine From structure to function] (in German). Nachtschatten Verlag AG. p. 766-771. ISBN 978-3-03788-700-4.
^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.